Molecular Epidemiology of Pediatric Germ Cell Tumors
Part of paid clinical trials in Minneapolis, Minnesota.
- Sponsor
- Children's Oncology Group
- Study ID
- NCT05564026
- Status
- Recruiting
Conditions
- Choriocarcinoma
- Embryonal Carcinoma
- Germ Cell Tumor
- Germinoma
- Late Effects
- Mixed Germ Cell Tumor
- Pediatric Germ Cell Tumor
- Teratoma
- Yolk Sac Tumor
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Questionnaire Administration — OTHERQuestionnaire provide to participant's about their health and quality of life since treatment
- Tumor Specimen Collection — OTHERTumor DNA requested from the Biopathology Center
- Germline DNA Samples — OTHERGermline DNA specimens requested from the Biopathology Center or newly collected saliva
- Blood Sample Collection — PROCEDURECollection and storing of serum/plasma
Study Details
A Non-Therapeutic Study that aims to establish a cohort of GCT survivors to understand short term and long-term adverse effects of treatment and to conduct molecular analyses to improve risk stratification.
Key Dates
- Start date
- Apr 12, 2023
- Status verified
- Sep 2025
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 1,151 participants (estimated)
Arms
- Arm: Ancillary-CorrelativeChildren and adolescents with a germ cell tumor, previously enrolled on APEC14B1 or AEPI10N1 who allow access to medical records (including audiograms), grant permission to: evaluate of all of their DNA, place their genetic and health information in scientific databanks, and collect a blood sample at a routine clinic/home visit, as well as complete a questionnaire about your health and quality of life since treatment.
Primary Outcome Measure
Ototoxicity [ Time Frame: Up to 5 years ]
Central Contacts
- Jenny Poynter(612) 625-4232
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Minnesota | Minneapolis | Minnesota | 55455 |
Find similar trials in Minneapolis, MN
By research site
Related Studies
- Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsPHASE3 · Recruiting · Children's Oncology Group · Birmingham, Alabama
- A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCTPHASE2 · Recruiting · Children's Oncology Group · Birmingham, Alabama
- Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsPHASE1 · Recruiting · Xencor, Inc. · Duarte, California
- A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPHASE2 · Recruiting · Children's Oncology Group · Mobile, Alabama